Voting Rights and Shares Update from Sanofi for 2025 Insights

Author: Owen Jenkins Updated: 10-14-2025 12:32 PM

Sanofi's Total Voting Rights and Shares Overview

Sanofi, a prominent name in the pharmaceutical industry, provides updates on the total number of voting rights and shares as part of the requirements set forth by the French Commercial Code. Their corporate structure allows them to operate effectively while maintaining compliance with regulatory standards.

Key Information Regarding Shares

Sanofi has a registered share capital of approximately €2.45 billion, emphasizing its robust financial standing. With the registered office located at 46, avenue de la Grande Armée, Paris, the company is officially documented under number 395 030 844 in the Paris Commercial and Companies Registry.

Current Share Details as of September 30, 2025

As of the latest reporting date, Sanofi has disclosed the following share statistics:

Total number of issued shares: 1,227,469,992
Number of real voting rights (excluding treasury shares): 1,352,290,790
Theoretical number of voting rights (including treasury shares): 1,361,772,559

The precise understanding of these figures is critical for investors and stakeholders, as it showcases Sanofi's commitment to transparency in its voting rights structure.

Importance of Voting Rights

Voting rights play a crucial role in corporate governance. They grant shareholders the power to influence major company decisions, which can ultimately impact financial performance. With more than a billion voting rights available, Sanofi allows its shareholders to actively participate in the governance processes.

Understanding the Shareholder Framework

Sanofi's governance framework is designed to foster shareholder engagement. By ensuring clarity regarding voting rights, shareholders can make informed decisions regarding their investments. Additionally, such transparency is essential for building trust within the investor community.

Staying Updated with Sanofi

Complete information about Sanofi's shares and voting rights is made available on their corporate website under the 'Regulated Information in France' section. Regular updates from such important data enable investors to stay informed about the company's structure and its implications for shareholders.

Contacting Investor Relations

Investors looking for more detailed information can reach out to Sanofi's Investor Relations Department via email at investor.relations@sanofi.com. This department is dedicated to addressing shareholder inquiries and providing relevant updates that might concern investor interests.

Frequently Asked Questions

What is the total number of shares issued by Sanofi?

As of September 30, 2025, Sanofi has issued a total of 1,227,469,992 shares.

How many real voting rights does Sanofi have?

Sanofi has approximately 1,352,290,790 real voting rights excluding treasury shares.

What is the theoretical number of voting rights including treasury shares?

The theoretical number of voting rights, including treasury shares, is 1,361,772,559.

Where can I find Sanofi's regulated information?

Sanofi's regulated information can be found on their corporate website under the "Regulated Information in France" section.

How can I contact Sanofi's investor relations?

You can contact Sanofi's Investor Relations Department through email at investor.relations@sanofi.com.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.